1. News | 2020.10.10

   The brain, this great unknown #podcast

   Neurology is an interdisciplinary field, in which research has evolved significantly in recent decades. At the Institut Pasteur, research is conducted on many subjects related to the brain such as degenerative diseases, memory, brain connectivity or sensory deficits. For the 2020 Pasteurdon (the Institut Pasteur’s public fundraising campaign), a podcast in French has been recorded. Two '...

2. News | 2020.10.09

   Fighting Cancer #podcast

   In 2018, 40,000 new cases of cancer were recorded in France, where this disease is the leading cause of death. Within the Institut Pasteur, more than 50 interdisciplinary teams are working on the subject. For the 2020 Pasteurdon (the Institut Pasteur’s public fundraising campaign), a podcast in French has been recorded. Two Pasteurian researchers, Sandrine Etienne-Manneville and Ludovic Deriano,...

3. News | 2020.10.08

   Antibiotics, when bacteria become resistant #podcast

   Antimicrobial resistance could become the leading cause of death in the world, with 10 million deaths in 2050, if nothing is done to prevent it. Today, 400,000 people die each year because of antibiotic resistance. The Institut Pasteur has made the study of bacterial resistance and the fight against resistant bacteria one of its priorities. On the occasion of Pasteurdon 2020 (the Institut...

4. News | 2020.10.07

   Emerging diseases and Covid-19 #Podcast

   Institut Pasteur's expertise in infectious diseases has made it one of the major players in research against Covid-19. For the 2020 Pasteurdon (the Institut Pasteur’s public fundraising campaign), a podcast in French has been recorded. Two Pasteurian researchers, Sylvie van der Werf and Arnaud Fontanet, talk about this pandemic and the Institut Pasteur's actions to fight the virus. They also...

5. Article | 2020.10.14

   Covid-19: vaccine against SARS-CoV-2 infection, using the measles vector

   Phase I testing in humans for the Institut Pasteur's SARS-CoV-2 vaccine candidate using the measles vector was lauchned in August 2020 in France and Belgium. Following the intermediate results of the Phase I clinical trial, the Institut Pasteur is stopping (January, 2021) development of the vaccine candidate based on the measles platform.  

6. Article | 2020.10.14

   Covid-19: A vaccine candidate using a lentiviral vector

   This vaccine candidate for the SARS-CoV-2 virus, designed for nasal administration, demonstrated intense protection and extremely high production of antibodies and cytotoxic cell responses in preclinical trials.

7. Article | 2020.10.14

   Covid-19: a DNA vaccine

   Of all the vaccines developed at the Institut Pasteur for SARS-CoV-2 (the virus that causes COVID-19), the DNA vaccine undoubtedly involves the most novel approach, since no vaccine using this technology has yet been commercialized* (for humans).

8. News | 2020.10.17

   Have I seen this before? Exploring the formation of distinct memories

   How do we form and use distinct memories of resembling events? Scientists at the Institut Pasteur (Paris) have combined imaging and behavioral recording techniques to measure the activity of neurons in the hippocampus of mice. According to their observations, the input region of the hippocampus detects small changes between familiar and novel environments, while the output region then weights...

9. News | 2020.10.15

   A Center for Research in Emerging Infectious Diseases, funded by NIH at the Institut Pasteur in Paris

   The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 11 grants to establish the Centers for Research in Emerging Infectious Diseases (CREID), including a coordinating center. One of those centers, and the sole center coordinated by a non-American organization, is the Pasteur International Center for Research on Emerging...

10. Document de presse | 2020.10.16

    Team of international scientists identify common vulnerabilities across SARS-CoV-2, SARS-CoV-1 and MERS coronaviruses

    Driven by Molecular Insights, Massive Analysis of Medical Records from ~740,000 SARS-CoV-2 Patients Reveal Treatment Regimens for Current, and Potential Future, Viral Pandemics. Published on October 15, 2020, in Science. In a study published online in Science, an international team of almost 200 researchers from 14 leading institutions in six countries, including France with the...

Pages